Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and anaerobic protozoan deoxyribonucleic acid (DNA) is the fundamental molecule carrying the genetic instructions for the development, functioning, and reproduction of these microorganisms. It is a critical therapeutic target for the nitroimidazole class of antibiotics, which are specifically effective against anaerobic bacteria and certain protozoa like Trichomonas vaginalis and Entamoeba histolytica (StatPearls, 2023). These drugs function as prodrugs that undergo reductive activation by microbial enzymes, such as pyruvate:ferredoxin oxidoreductase, which are unique to anaerobic metabolism (PubChem). The resulting highly reactive nitro radical anions interact directly with the DNA, causing loss of helical structure and extensive strand breakage. This damage effectively halts DNA replication and transcription, leading to rapid microbial cell death. Because the activation process requires an anaerobic or microaerophilic environment, this mechanism provides selectivity against anaerobic bacteria and certain protozoa while sparing aerobic host cells.
Nitroimidazoles enter the cell by passive diffusion and are reduced by the pyruvate:ferredoxin oxidoreductase (PFOR) system in anaerobic organisms. This reduction produces reactive nitro radical anions that cause DNA strand breakage and destabilization of the helical structure, leading to inhibition of nucleic acid synthesis and cell death (StatPearls, 2023; PubChem).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and anaerobic protozoan deoxyribonucleic acid (DNA).